» Articles » PMID: 15941072

The European Competence Network on Mastocytosis (ECNM)

Abstract

The European Competence Network on Mastocytosis (ECNM) is a Europe-wide, multinational cooperative approach attempting to improve recognition, diagnosis, and therapy of mastocytosis. The network is composed of local centers, physicians, and scientists who have dedicated their work to patients with mastocytosis. However, because of the rarity and complexity of the disease, each single component in the network alone would fail to meet important demands and to reach solid conclusions in this field of applied medicine. The ECNM represents an attempt to overcome this restriction as a cooperative multicenter platform that should serve as an important basis for the development of new therapeutic strategies and diagnostic concepts, and for the standardization of techniques used to determine diagnostic and prognostic parameters. Moreover, using future central databases and registries, a suitable infrastructure for the development of co-operative multicenter clinical trials will be established. In addition, the ECNM is dedicated to provide the best available information about the disease to patients and physicians.

Citing Articles

Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.

Lubke J, Schmid A, Christen D, Oude Elberink H, Span L, Niedoszytko M Blood Adv. 2024; 8(11):2890-2900.

PMID: 38593217 PMC: 11214361. DOI: 10.1182/bloodadvances.2024012756.


The influence of nutritional habits, body mass index and intestinal microbiota in mastocytosis on clinical symptoms using conventional culture and next generation sequencing.

Harceko-Zielinska E, Niedoszytko M, Gorska A, Malgorzewicz S, Gruchala-Niedoszytko M, Bronk M Clin Transl Allergy. 2024; 14(1):e12310.

PMID: 38282197 PMC: 10787583. DOI: 10.1002/clt2.12310.


Modulation of dermal equivalent of hypothalamus-pituitary-adrenal axis in mastocytosis.

Antoniewicz J, Nedoszytko B, Lange M, Wierzbicka J, Gorska-Ponikowska M, Niedoszytko M Postepy Dermatol Alergol. 2021; 38(3):461-472.

PMID: 34377129 PMC: 8330854. DOI: 10.5114/ada.2021.107933.


Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference.

Gotlib J, George T, Carter M, Austen K, Bochner B, Dwyer D J Allergy Clin Immunol. 2021; 147(6):2043-2052.

PMID: 33745886 PMC: 9521380. DOI: 10.1016/j.jaci.2021.03.008.


New developments in the field of mastocytosis and mast cell activation syndromes: a summary of the Annual Meeting of the European Competence Network on Mastocytosis (ECNM) 2019.

Arock M, Sotlar K, Gotlib J, Sperr W, Hartmann K, Schwartz L Leuk Lymphoma. 2019; 61(5):1075-1083.

PMID: 31876203 PMC: 7115828. DOI: 10.1080/10428194.2019.1703974.